Cargando…
Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions
PURPOSE: Intravitreal recombinant tissue plasminogen activator (rtPA) is used off-label for the surgical management of submacular hemorrhage, a severe complication of neovascular age-related macular degeneration. rtPA is approved for coronary and cerebral thrombolysis. However, in ischemic stroke rt...
Autores principales: | Daruich, Alejandra, Parcq, Jérôme, Delaunay, Kimberley, Naud, Marie-Christine, Le Rouzic, Quentin, Picard, Emilie, Crisanti, Patricia, Vivien, Denis, Berdugo, Marianne, Behar-Cohen, Francine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108461/ https://www.ncbi.nlm.nih.gov/pubmed/27881907 |
Ejemplares similares
-
Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case series
por: Chakraborty, Debdulal, et al.
Publicado: (2022) -
Successful systemic thrombolysis with rtPA in a patient with history of a life-threatening rtPA-associated orolingual angioedema
por: Pelz, Johann Otto, et al.
Publicado: (2017) -
Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models
por: Daruich, Alejandra, et al.
Publicado: (2022) -
Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model
por: Berdugo, Marianne, et al.
Publicado: (2021) -
Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system
por: Masomi-Bornwasser, Julia, et al.
Publicado: (2017)